You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Primary Progressive Multiple Sclerosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mitochondrial Dysfunction in Primary Progressive Multiple

Recruiting
  • Multiple Sclerosis
    • Milan, MI, Italy
    • +1 more
    Aug 29, 2023

    Ocrelizumab on Choroid Plexus Changes in Patients With PPMS

    Not yet recruiting
    • Primary Progressive Multiple Sclerosis
    • Ocrelizumab
    • Buffalo, New York
      Buffalo Neuroimaging Analysis Center
    Jul 26, 2023

    Ocrelizumab on Cortical Lesion Accumulation in PPMS

    Not yet recruiting
    • Primary Progressive Multiple Sclerosis
    • Ocrelizumab
    • (no location specified)
    Aug 2, 2023

    Gray Matter Demyelination in Primary Progressive MS at 7T

    Recruiting
    • Primary Progressive Multiple Sclerosis
      • Hvidovre, Denmark
        Danish Research Centre for Magnetic Resonance
      Jun 5, 2022

      Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary-progressive Multiple Sclerosis Trial in Belgium (Metformin

      Not yet recruiting
      • Multiple Sclerosis
      • +2 more
      • Metformin Hydrochloride 850 mg Oral Tablet
      • Placebo
      • Brugge, Belgium
      • +4 more
      May 30, 2023

      Primary Progressive Multiple Sclerosis Trial in Durham (DUOC-01)

      Recruiting
      • Primary Progressive Multiple Sclerosis
      • DUOC-01
      • Durham, North Carolina
        Duke University Medical Center
      Jan 25, 2022

      Primary Progressive Multiple Sclerosis, Exercise, Cardiorespiratory Fitness Trial in Valens (HIIT, MCT)

      Recruiting
      • Primary Progressive Multiple Sclerosis
      • +2 more
      • HIIT
      • MCT
      • Valens, Sankt Gallen, Switzerland
        Klinik Valens, Valens rehabilitation clinic
      Jun 9, 2022

      Multiple Sclerosis Trial in Telese Terme, Napoli (quantification of sensory and autonomic small nerve fibers by punch skin

      Recruiting
      • Multiple Sclerosis
      • quantification of sensory and autonomic small nerve fibers by punch skin biopsy
      • +2 more
      • Telese Terme, Benevento, Italy
      • +1 more
      Feb 17, 2023

      Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Los Angeles (Metformin 500 Mg Oral

      Recruiting
      • Secondary Progressive Multiple Sclerosis
      • Primary Progressive Multiple Sclerosis
      • Metformin 500 Mg Oral Tablet, up to 4 tablets a day
      • Placebo oral tablet identical to metformin, up to 4 tablets a day
      • Los Angeles, California
        University of California, Los Angeles
      May 2, 2022

      Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Multiple Sclerosis Trial (Intranasal Foralumab

      Withdrawn
      • Primary Progressive Multiple Sclerosis
      • +2 more
      • Intranasal Foralumab Solution
      • Placebo
      • (no location specified)
      Feb 14, 2022

      Primary Progressive Multiple Sclerosis Trial in Israel, Moldova, Republic of (GA Depot 40mg once monthly, GA Depot 25mg once

      Recruiting
      • Primary Progressive Multiple Sclerosis
      • GA Depot 40mg once monthly
      • GA Depot 25mg once monthly
      • Haifa, Israel
      • +6 more
      Oct 30, 2022

      Multiple Sclerosis, Primary Progressive Trial in Bordeaux, Limoges, Poitiers (Clinical assessment, Ecological evaluation,

      Recruiting
      • Multiple Sclerosis, Primary Progressive
      • Clinical assessment
      • +4 more
      • Bordeaux, France
      • +2 more
      Mar 31, 2022

      Upper Extremity Function in Multiple Sclerosis Advanced

      Active, not recruiting
      • Multiple Sclerosis
      • +7 more
      • Tampa, Florida
        Carol and Frank Morsani Center for Advanced Healthcare
      Nov 2, 2022

      Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

      Not yet recruiting
      • Multiple Sclerosis
      • +2 more
      • KYV-101 anti-CD19 CAR-T cell therapy
      • Standard lymphodepletion regimen
      • Palo Alto, California
        Stanford Multiple Sclerosis Center
      Nov 13, 2023

      Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis Trial

      Active, not recruiting
      • Secondary Progressive Multiple Sclerosis
      • +2 more
      • Minneapolis, Minnesota
      • +2 more
      Mar 29, 2022

      Multiple Sclerosis (MS) Patients

      Not yet recruiting
      • Multiple Sclerosis, Relapsing-Remitting
      • +2 more
        • (no location specified)
        Dec 15, 2022

        Relapsing Remitting Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial

        Recruiting
        • Relapsing Remitting Multiple Sclerosis
        • +2 more
        • Ixazomib (NINLARO®) capsules / Matching placebo capsules
        • London, Greater London, United Kingdom
          Royal London Hospital, Barts Health NHS Foundation Trust
        Feb 17, 2022

        Relapsing Multiple Sclerorsis, Multiple Sclerosis, Primary Progressive Trial in Worldwide (Ocrelizumab, Lumbar Puncture,

        Active, not recruiting
        • Relapsing Multiple Sclerorsis
        • Multiple Sclerosis, Primary Progressive
        • Palo Alto, California
        • +16 more
        Jul 26, 2022

        Multiple Sclerosis, Primary Progressive Trial in Calgary (Hydroxychloroquine)

        Completed
        • Multiple Sclerosis, Primary Progressive
        • Calgary, Alberta, Canada
          MS Clinic Foothills Medical Centre
        Jul 28, 2021

        Imaging Interplay Between Axonal Damage and Repair in Multiple

        Recruiting
        • Multiple Sclerosis (MS)
        • +3 more
        • MRI
        • +2 more
        • Basel, Switzerland
          University Hospital Basel, Department of Neurology
        Dec 15, 2021

        Progressive Multiple Sclerosis Trial in Lille, Strasbourg (Placebo, Masitinib (4.5))

        Recruiting
        • Progressive Multiple Sclerosis
        • Placebo
        • Masitinib (4.5)
        • Lille, France
        • +1 more
        Jul 1, 2022

        Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial run by the NIAID (Idebenone)

        Completed
        Has Results
        • Multiple Sclerosis
        • Primary Progressive Multiple Sclerosis
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Apr 27, 2021

        Multiple Sclerosis (MS), Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive Trial in San Francisco

        Not yet recruiting
        • Multiple Sclerosis (MS)
        • +6 more
        • Clemastine Fumarate
        • Placebo
        • San Francisco, California
          Sandler Neurosciences Building, Neurological Clinical Research U
        Jan 23, 2023

        Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive

        Completed
        • Multiple Sclerosis, Relapsing-Remitting
        • +2 more
        • 18F-DPA-714 and 18F-FDG
        • Paris, France
        • +1 more
        Sep 14, 2022

        Primary Progressive Multiple Sclerosis the MURDOCK Study

        Completed
        • Primary Progressive Multiple Sclerosis
        • generation of 'omic markers of disease progression
        • Concord, North Carolina
        • +2 more
        May 26, 2021